Back to top

CVRx’s REBALANCE Registry Update: What the Termination Means for Barostim Investors

Cvrx, Inc. ($CVRX) announced an update on their ongoing clinical study. The REBALANCE Registry from CVRx, Inc. tracks real-world use of the Barosti...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

CVRx, Inc. (CVRX)